Edratide

N/A

Report date: 2022/11/25 17:43:10
NME

Base Information

Drug NameEdratide
Drug Alias Nameedratida依屈肽edratidumhCDR1TV-4710
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsLupus Erythematosus, Systemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesWeizmann Institute Of Science
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiossil IncTeva Branded Pharmaceutical Products R&D Inc
Active IndicationsN/A
Inactive IndicationsLupus Erythematosus, Systemic

Other Information

ATC CodeN/A
Related LinksN/A